Spotlight on Young Researchers: The role a gene plays in neurodegeneration and cancer

 

Neurodegenerative diseases and cancer affect millions of people worldwide, especially people over 60. While advances in diagnosis and treatment have been made, there are still many open questions on the path to better treatment and earlier diagnosis. Translational neuroscientist  Pauline Mencke studies a gene that is involved both in Parkinson’s disease and the brain cancer Glioblastoma multiforme.

Parkinson’s disease (PD) is the second most common neurodegenerative disease affecting 1-2% of the world’s population over the age of 60. The disease mainly manifests as impaired movement, caused by the loss of specific nerve cells in the brain that are responsible for controlling movement initiation.

Over the years, scientists have identified many genes that are causative for monogenic forms of PD, but efforts continue to find ways to improve treatment and diagnosis: So far, there is no cure for PD and no treatment that will stop the progress of the disease, which is why current treatment strategies are only symptomatic.

Glioblastoma multiforme (GBM) is the most malignant brain tumour, responsible for around 2.5% of cancer deaths worldwide. The age range of GBM patients is quite wide, ranging from approximately 45-75 years. GBM is characterized by poor prognosis, low survival rates, and extremely limited opportunities for therapy. Current standard therapy is a combination of maximal safe surgical resection of the tumour and subsequent radiation and chemotherapy. However, even with advances in surgical resection, the prognosis for GBM patients remains very poor: Around 75% of GBM patients die within 12 months of their diagnosis – only around 5% survive for five years or longer.

"Here, I am looking at cells that I am cultivating for my project. I need to check my cells every day under the microscope to assess their condition. "

Understanding the gene PARK7 encoding the protein DJ-1 to find common disease mechanisms

What do Parkinson’s disease and Glioblastoma multiforme have in common?

“Due to the complexity and heterogeneity of PD, the etiology is not yet fully understood. This is why there is no cure for the disease”, explains biologist Pauline Mencke.

“In the same manner, GBM is a very heterogeneous and complex disease, meaning that it is very difficult to identify individual causes and treatment strategies that are tumour specific.”

In the last years, there has been increasing evidence that a specific gene encoding the protein DJ-1 is associated with both diseases. As part of her PhD project, biologist Pauline Mencke is studying the role of DJ-1 in more detail:

“We know that genes that are upregulated in cancer are frequently downregulated in PD and vice versa.”, Pauline explains.

“Interestingly, increased expression of some PD-associated genes like one called ‘PARK7 (DJ-1)’ influence cell proliferation and metabolism, meaning they support tumorigenesis – the formation of tumours.”

“In PD, the effect reverses, as loss of DJ-1 protein function causes PD. In the scope of my PhD project, we are simultaneously studying the role and function of DJ-1 in PD and GBM to better understand its role in both conditions.”

A collaborative effort

Pauline collaborates with several scientists for her project, both in Luxembourg and abroad:

“The PD-patient derived iPSCs [stem cells] that I am using for my project were obtained from fibroblasts from a collaboration with Prof. Dr. med. Vincenzo Bonifati from Rotterdam.

“For the CRISPR Cas9 mediated correction of the mutation in the iPSCs, I profited from the expertise of Dr. Javier Jarazo from the LCSB. I am also collaborating with ATTRACT Fellow Dr. Johannes Meiser from the LIH, who is helping me through his expertise in metabolomics.

“Finally, in collaboration with Dr. Carole Linster from the LCSB, we are trying to identify enzymatic functions of DJ-1, while Prof. Dr. med. Michael Platten from the DKFZ in Heidelberg is advising me with his excellent experience in Glioblastoma research.”

The aim of the research is to identify common mechanisms shared by the diseases – this would allow for the identification of a common pathway and potential drug target, ultimately improving the outlook for patients.

Pauline Mencke, 3rd year PhD candidate at the Luxembourg Centre for Systems Biomedicine (LCSB). Her PhD is supported by an AFR grant from the FNR.


"Cells need to be supplied with nutrients that are added as cell specific media every day or every other day."
As the main readout for the analysis of the cultured cells is metabolomics, I perform many metabolite extractions for subsequent mass spectrometry analysis that require preparation before starting the experiment.
Pauline Mencke

RELATED PROGRAMMES

MORE ABOUT PAULINE MENCKE

On progress already made during her current project

“I corrected the DJ-1 mutation in PD-patient-derived cells to generate isogenic controls. Using these models, I found that DJ-1 deficiency affects astrocytes more than neurons regarding their metabolism. Knockdown of DJ-1 in GBM cells has a similar effect as in astrocytes, suggesting a common mechanism in PD and GBM.”

On choosing Luxembourg as a research destination

“I have studied molecular medicine in Regensburg (Germany) and from the beginning of my studies, I was interested in translational medicine, studying causes and mechanisms of diseases to help to identify better treatments. During my master studies in Luxembourg, I met Prof. Dr. med. Rejko Krüger and learned about his excellent research. This is why I decided to do my PhD in his highly interdisciplinary translational group.”

More about Pauline Mencke’s research:

Mencke P, Hanss Z, Boussaad I, Sugier PE, Elbaz A, Krüger R. Bidirectional Relation Between Parkinson’s Disease and Glioblastoma Multiforme. Front Neurol. 2020 Aug 20;11:898. doi: 10.3389/fneur.2020.00898. PMID: 32973662; PMCID: PMC7468383.

Mencke P, Boussaad I, Romano CD, Kitami T, Linster CL, Krüger R. The Role of DJ-1 in Cellular Metabolism and Pathophysiological Implications for Parkinson’s Disease. Cells. 2021 Feb 7;10(2):347. doi: 10.3390/cells10020347. PMID: 33562311; PMCID: PMC7915027.

About Spotlight on Young Researchers

Spotlight on Young Researchers is an FNR initiative to highlight early career researchers across the world who have a connection to Luxembourg, with nearly 100 features published since 2016.

More in the series SPOTLIGHT ON YOUNG RESEARCHERS

  • All
  • Cancer research
  • Environmental & Earth Sciences
  • Humanities & Social Sciences
  • Information & Communication Technologies
  • Law, Economics & Finance
  • Life Sciences, Biology & Medicine
  • Materials, Physics & Engineering
  • Research meets industry
  • Women in science

Spotlight on Young Researchers: Overcoming antiquated ideas about history

Spotlight on Young Researchers: Glioblastoma and the challenge of getting cancer drugs to reach the brain

Spotlight on Young Researchers: Identifying environmental pollutants

Spotlight on Young Researchers: Understanding drug resistance in skin cancer

Spotlight on Young Researchers: Towards predicting ageing-related diseases

Spotlight on Young Researchers: Are you what you eat?

Spotlight on Young Researchers: AI for ethical and legal debates

Spotlight on Young Researchers: How is scientific quality fostered by research collaboration?

Spotlight on Young Researchers: Turning up the heat on solar absorbers

Spotlight on Young Researchers: Ramping up carbohydrates production

Spotlight on Young Researchers: Empowering critical digital humanities practice

Spotlight on Young Researchers: A gas sensor powered by natural light

Spotlight on Young Researchers: A hazelnut quality forecasting system

Spotlight on Young Researchers: Steve Dias Da Cruz

Spotlight on Young Researchers: Martin Řehoř

Spotlight on Young Researchers: Sumit Gautam

Spotlight on Young Researchers: Lucas Oesch

Spotlight on Young Researchers: Understanding how language manifests in the brain

Spotlight on Young Researchers: Hameeda Jagalur Basheer

Spotlight on Young Researchers: Mohammad Zare

Spotlight on Young Researchers: Yamila Mariel Omar

Spotlight on Young Researchers: Bella Tsachidou

Spotlight on Young Researchers: Antonio Ancora

Spotlight on Young Researchers: Paul Johanns

Spotlight on Young Researchers: Understanding brain mechanisms behind eating disorders

Spotlight on Young Researchers: Nathasia Mudiwa Muwanigwa

A system to support forest ecosystem decision-making

Spotlight on Young Researchers: Noémie Catherine Engel

Spotlight On Young Researchers: Henderika de Vries

Spotlight on Young Researchers: Remko Nijzink

Spotlight on Young Researchers: Anjali Sharma

Spotlight on Young Researchers: Pier Mario Lupinu

Spotlight on Young Researchers: Nanotechnology – a future big player in health

Spotlight on Young Researchers: Foni Raphaël Lebrun-Ricalens

Spotlight on Young Researchers: Christof Ferreira Torres

Spotlight on Young Researchers: Understanding our immune system

Spotlight on Young Researchers: Silvia Girardi

Spotlight on Young Researchers: Carole Lara Veiga de Sousa

Spotlight on Young Researchers: Adham Ayman Al-Sayyad

Spotlight on Young Researchers: Thomas Schaubroeck

Spotlight on Young Researchers: Sebastian Scheer

Spotlight on Young Researchers: Damien Brevers

Spotlight on Young Researchers: Nature does it best

Spotlight on Young Researchers: Jose-Luis Sanchez-Lopez

Spotlight on Young Researchers: Ernesto Gargiulo

Spotlight on Young Researchers: Thomas Elliot

Spotlight on Young Researchers: Maciej Piotr Chrzanowski

Spotlight on Young Researchers: Max Hilaire Wolter

Spotlight on Young Researchers: Dominique Santana

Spotlight on Young Researchers: Gilles Tossing

Spotlight on Young Researchers: László Sándor

Spotlight on Young Researchers: Ramona Pelich

Spotlight on Young Researchers: Maxime Brami

Spotlight on Young Researchers: Anna Monzel

Spotlight on Young Researchers: Konstantinos Papadopoulos

Spotlight on Young Researchers: Laurie Maldonado

Spotlight on Young Researchers: Antoun Al Absi

Spotlight on Young Researchers: Katharina Baum

Spotlight on Young Researchers: Michel Summer

Spotlight on Young Researchers: Amy Parrish

Spotlight on Young Researchers: German Castignani

Spotlight on Young Researchers: Eva Lagunas

Spotlight on Young Researchers: Michel Thill

Spotlight on Young Researchers: Maria Pires Pacheco

Spotlight on Young Researchers: Miguel Angel Olivares Mendez

Spotlight on Young Researchers: Zhe Liu

Spotlight on Young Researchers: Xianqing Mao

Spotlight on Young Researchers: Lisa Hefele

Spotlight on Young Researchers: Hussein Rappel

Spotlight on Young Researchers: Taking language barriers out of the equation

Spotlight on Young Researchers: Gil Georges

Spotlight on Young Researchers: Isabel Z. Martínez

Spotlight on Young Researchers: Charles de Bourcy

Spotlight on Young Researchers: Pit Losch

Spotlight on Young Researchers: Svenja Bourone

Spotlight on Young Researchers: Kacy Greenhalgh

Spotlight on Young Researchers: Paul Hauseux

Spotlight on Young Researchers: Léon-Charles Tranchevent

Spotlight on Young Researchers: Multiple nationalities, one goal

Spotlight on Young Researchers: Eric Finn Schaanning

Spotlight on Young Researchers: Jo Hoeser

Spotlight on Young Researchers: Anna Schleimer

Spotlight on Young Researchers: Paulo Carvalho

Spotlight on Young Researchers: Guillaume Nataf

Spotlight on Young Researchers: Alex Gansen

Spotlight on Young Researchers: Anna Scaini

Spotlight on Young Researchers: Chetan Arora

Spotlight on Young Researchers: Pit Ullmann

Spotlight on Young Researchers: Nina Hentzen

Spotlight on Young Researchers: Dimitra Anastasiou

Spotlight on Young Researchers: Cyrille Thinnes

Latest features about Parkinson’s disease and cancer research

  • All
  • Cancer research
  • Information & Communication Technologies
  • Life Sciences, Biology & Medicine
  • Science outreach
  • Women in science

Spotlight on Young Researchers: Towards predicting ageing-related diseases

Wastewater reveals clues about microorganisms, holds promise for future microbiome engineering

NCER-PD: Excellent results rewarded with a second funding period

What microbes really do in our guts

Genetic forms of Parkinson’s disease: Stem cell research offers new insights

Turning ‘cold’ tumours ‘hot’: A novel approach to improved cancer immunotherapy

Fighting autoimmunity and cancer: The nutritional key

Spotlight on Young Researchers: Nathasia Mudiwa Muwanigwa

Luxembourg Parkinson’s Study: 1600 participants recruited!

Toward a better understanding and diagnosis of neurodegeneration and brain tumours

Microbiome research: unlocking basic unknowns in human health

Diet and bacteria combination limits cancer progression

Connecting fundamental research and clinical care

Shedding light on how colon cancer develops and progresses

From flood prediction to deep brain stimulation

FNR ATTRACT Fellows – the people behind the science: Anne Grünewald

Does Parkinson’s disease originate outside the brain? FNR ATTRACT Fellow leads study suggesting gut bacteria could play a role

Researchers’ Days: What it feels like to have Parkinson’s disease

NCER-PD: Meet Dany, the 100th Parkinson’s study control person

This site uses cookies. By continuing to use this site, you agree to the use of cookies for analytics purposes. Find out more in our Privacy Statement